Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: A randomized comparison

American Journal of Gastroenterology

Volumn 100, Issue 3, 2005, Pages 631-635

  Baik, Soon Koo ^a   Jeong, Phil Ho ^b   Ji, Sang Won ^b   Yoo, Byung Su ^b   Kim, Hyun Soo ^b   Lee, Dong Ki ^b   Kwon, Sang Ok ^b   Kim, Young Ju ^b   Park, Joong Wha ^b   Chang, Sei Jin ^b   Lee, Samuel S ^b  

^a Yonsei University Wonju   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; TERLIPRESSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEART RATE; HEMODYNAMICS; HEPATIC VENOUS PRESSURE; HUMAN; LIVER CIRRHOSIS; MALE; MEAN ARTERIAL PRESSURE; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRESSURE GRADIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VENOUS PRESSURE;

BLOOD PRESSURE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL AGENTS; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRAVENOUS; LIVER CIRCULATION; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; OCTREOTIDE; PORTAL SYSTEM; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASOCONSTRICTOR AGENTS; VENOUS PRESSURE;

EID: 20144389166     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41381.x     Document Type: Article

References (33)

1. D'Amico G, Pietrosi G, Tarantino I, et al. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: A Cochrane meta-analysis. Gastroenterology 2003;124:1277-91.
2. Corley DA, Cello JP, Adkisson W, et al. Octreotide for acute esophageal variceal bleeding: A meta-analysis. Gastroenterology 2001;120:946-54.
3. Ioannou GN, Doust J, Rockey DC. Systematic review: Terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003;17:53-64.
4. Silvain C, Carpentier S, Sautereau D, et al. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial. Hepatology 1993;18:61-5.
5. Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
6. McCormick PA, Biagini MR, Dick R, et al. Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients withportal hypertension: A double-blind, placebo-controlled study. Hepatology 1992;16:1180-6.
7. Burroughs AK. Pharmacological treatment of acute variceal bleeding. Digestion 1998;59(Suppl 2):28-36.
8. Escorsell À, Bandi JC, Andreu V, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 2001;120:161-9.
9. Lin HC, Tsai YT, Lee FT, et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992;103:229-34.
10. Moller S, Brinch K, Henriksen JH, et al. Effect of octreotide on systemic, central and splanchnic hemodynamics in cirrhosis. J Hepatol 1997;26:1026-33.
11. Eriksson LS, Brundin T, Söderlund C, et al. Hemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987;22:919-25.
12. Pringle SD, McKee RF, Garden OJ, et al. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis. Aliment Pharmacol Ther 1988;2:451-9.
13. Escorsell À, Bandi JC, Moitinho E, et al. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 1997;26:621-7.
14. Lin HC, Yang YY, Hou MC, et al. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis. Scand J Gastroenterol 2002;37:482-7.
15. Therapondos G, Stanley AJ, Hayes PC. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: Pilot study. J Gastroenterol Hepatol 2004;19:73-7.
16. Vachiery F, Moreau R, Gadano A, et al. Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker. Dig Dis Sci 1996;41:1722-6.
17. Valla D, Lee SS, Moreau R, et al. Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis. Gastroenterol Clin Biol 1985;9:877-80.
18. Choi YJ, Baik SK, Park DH, et al. Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol 2003;18:424-9.
19. Baik SK, Park DH, Kim MY, et al. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity. J Gastroenterol 2003;38:1150-4.
20. Schepke M, Raab P, Hoppe A, et al. Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis. Aliment Pharmacol Ther 1999;13:1451-8.
21. Schiedermaier P, Hansen S, Asdonk D, et al. Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics: A double-blind, cross-over, placebo-controlled study in healthy volunteers. Digestion 2000;61:107-12.
22. Ferguson JW, Tripathi D, Hayes PC. Review article: The management of acute variceal bleeding. Aliment Pharmacol Ther 2003;18:253-62.
23. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-48.
24. Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 2002;35:1305-12.
25. Chatila R, Ferayorni L, Gupta T, et al. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Hepatology 2000;31:572-6.
26. Cirera I, Feu F, Luca A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double-blind hemodynamic investigation. Hepatology 1995;22:106-11.
27. McCormick PA, Chin J, Greenslade L, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995;21:1255-60.
28. Gaudin C, Moreau R, Champigneulle B, et al. Short-term cardiovascular effects of somatostatin in patients with cirrhosis. Liver 1995;15:236-41.
29. Cerini R, Lee SS, Hadengue A, et al. Circulatory effects of somatostatin analogue in two conscious rat model of portal hypertension. Gastroenterology 1988;94:703-8.
30. Romero G, Kravetz D, Argonz J, et al. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients. J Hepatol 2000;32:419-25.
31. D'amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: An evidence-based approach. Semin Liver Dis 1999;19:475-505.
32. Hwang SJ, Lin HC, Change FG, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal hemorrhage. J Hepatol 1992;16:320-5.
33. Sung JJY, Chung SCS, Yung MY, et al. Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346:1666-9.